Capsid & Tail
Loading issues…
- Digital phagograms: how can we predict phage infectivity?As the field of phage research is increasingly becoming data-driven and intertwined with artificial intelligence (AI), predicting phage-host interactions can provide new biological insights and support the development of personalized phage…
- All good things come in fours: a sneak peek at the 4th annual Bacteriophage Therapy SummitFrom Feb 14th-16th, the who's who of the phage world is getting together to discuss everything from isolating phages from hospital wastewater to the role of the immune system in phage therapy!
This week, University of Vienna MSc student…
- C&T Round Up for Dec & Jan!This week, we highlight the features we published in Dec & Jan! Learn about combining phages with antibiotics, scaling up phage production, the new Web3 x science movement, and catch Phage Directory's 2021 reflection and 2022 outlook!
- Let's focus the power of Web3 on science & biotech's problemsPhage Directory started because Jan (a 'tech person') saw how his skills could help fix inefficiencies in Jessica's field: phage biology. Now, more people like Jan are getting excited to focus on solving problems in science/biology/biotech…
- Which single-use bioreactor is right for me?A bioreactor should provide the ideal environment for cells (and by extension, phages!). But choosing your setup can be tough. This week, Robert Matthew from Cellexus provides a nice explainer to help you understand your options!
- 2022: Building the Operating System for Phage TherapyGood morning, 2022! We’re extremely proud of our work empowering the community, running events like Evergreen and building Instill. This year, we'll be focused on building the “operating system” for phage therapy. From lab workflows to web…
- Reflecting back on 2021It's our last issue of the year! We reflect on what we're especially proud of from this year, and highlight some stats on where we're at as a community!
Also: a giant thanks to each of our amazing volunteers!
- Molecular multitasking: inhibition of phage infection by aminoglycoside antibioticsIn our PHAVES series this fall, Aël Hardy, PhD student at Forschungszentrum Jülich, Germany, spoke about his research into the inhibition of phage infection by aminoglycoside antibiotics. Here’s the recording, along with a recap by Sayde…
- C&T Round Up for November 2021This week, we highlight the feature articles we published in November! Learn about optimizing the route for phage delivery, single use bioreactor technologies vs. traditional solutions, and phage therapy to combat a shell infection in a sea…
- Flipping the turtle back on its flippers: Phage therapy to combat a shell infection in a sea turtleRemember when Shelley the sea turtle got phage therapy, thanks to the phage community? This week, Stephanie Lynch distills main learnings from the paper and shares her interview with Shelley's vet, plus a webinar/Q&A that dives deeper!
- The Modern Laboratory: Single use bioreactor technologies vs. traditional solutionsThis week, we've got a discussion on the advantages, disadvantages and comparative costs of single use bioreactors vs. traditional solutions, written by Adam Ostrowski, Technical Application Specialist at Cellexus.
- Optimising the route for phage deliveryThis week, Lizzie Richardson brings us a guest post on optimising the route for phage delivery.
- C&T Round Up for October 2021This week, we highlight the feature articles we published in October! Learn about the phages being collected around the world, a doctor-patient experience with phage therapy, successful use of phage to treat bacterial prostatitis, and…
- Overcoming barriers to phage commercialization: a conversation with leaders at Cytophage and BiomXThis week, McMaster University PhD student Kyle Jackson interviews Cytophage and BiomX executives, who share phage therapy commercialization challenges and progress and a sneak peek into what they'll present at Phage Futures.
You can also…
- Phage therapy successfully treats bacterial prostatitis after multiple failed antibiotic treatments – Behind the case reportThis week, Apurva Virmani Johri and Pranav Johri of Vitalis Phage Therapy take us behind their recently published phage therapy case report, which describes the successful treatment of a patient with prostatitis using phages (done at the…
- Phage therapy: a doctor-patient experienceIn our PHAVES series this summer, Dr. Gina Suh, an infectious disease physician at the Mayo Clinic, and John Haverty, a phage therapy patient, spoke about phage therapy from a doctor's and patient's perspective. Here’s the recording, along…
- State of Phage #3: Exploring phage collectionsWe're compiling the results of our State of Phage 2020 Survey, and we're excited to show you a third snapshot of the findings! Today we're focusing on phage collections; which phages are labs collecting, how many do they have of each, and…
- C&T Round Up for September 2021This week, we highlight the four feature articles we published in September! Learn about a new plaque counting app by Michael Shamash, a new plaque sizing tool by Ellina Trofimova, how Australian pediatrician Ameneh Khatami is treating kids…
- A Window into Evergreen 2021 from the Next Generation of Phage ResearchersThis week, we're featuring an article co-published with PHAGE Journal highlighting a selection of talks from the Evergreen 2021 conference, written by a group of phage-enthusiastic students and postdocs who attended!
This week's feature…
- Plaque size tool: an easy bioinformatics instrument for phage plaque size measurementsThis week, we’re featuring a post by Ellina Trofimova, software engineer-turned-MSc student at Macquarie University in Australia. She tells us about the Plaque Size Tool she’s developed, including how it came about and what it can do!
